These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


277 related items for PubMed ID: 19089943

  • 1. Functional implications of membrane modification with semenogelins for inhibition of sperm motility in humans.
    Yoshida K, Krasznai ZT, Krasznai Z, Yoshiike M, Kawano N, Yoshida M, Morisawa M, Tóth Z, Bazsáné ZK, Márián T, Iwamoto T.
    Cell Motil Cytoskeleton; 2009 Feb; 66(2):99-108. PubMed ID: 19089943
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Physiological roles of semenogelin I and zinc in sperm motility and semen coagulation on ejaculation in humans.
    Yoshida K, Kawano N, Yoshiike M, Yoshida M, Iwamoto T, Morisawa M.
    Mol Hum Reprod; 2008 Mar; 14(3):151-6. PubMed ID: 18203809
    [Abstract] [Full Text] [Related]

  • 4. Semenogelin, the main protein of the human semen coagulum, regulates sperm function.
    de Lamirande E.
    Semin Thromb Hemost; 2007 Feb; 33(1):60-8. PubMed ID: 17253191
    [Abstract] [Full Text] [Related]

  • 5. Incidence of sperm-tail tyrosine phosphorylation and hyperactivated motility in normozoospermic and asthenozoospermic human sperm samples.
    Yunes R, Doncel GF, Acosta AA.
    Biocell; 2003 Apr; 27(1):29-36. PubMed ID: 12847912
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Protease activated receptor 2 and epidermal growth factor receptor are involved in the regulation of human sperm motility.
    Zitta K, Albrecht M, Weidinger S, Mayerhofer A, Köhn F.
    Asian J Androl; 2007 Sep; 9(5):690-6. PubMed ID: 17712488
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Quantification of seminal plasma motility inhibitor/semenogelin in human seminal plasma.
    Yoshida K, Yamasaki T, Yoshiike M, Takano S, Sato I, Iwamoto T.
    J Androl; 2003 Sep; 24(6):878-84. PubMed ID: 14581514
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Collection method, season and individual variation on seminal characteristics in the llama (Lama glama).
    Giuliano S, Director A, Gambarotta M, Trasorras V, Miragaya M.
    Anim Reprod Sci; 2008 Mar 03; 104(2-4):359-69. PubMed ID: 17383121
    [Abstract] [Full Text] [Related]

  • 19. Blocking serine protease activity prevents semenogelin degradation leading to hyperviscous semen in humans.
    Anamthathmakula P, Erickson JA, Winuthayanon W.
    Biol Reprod; 2022 May 17; 106(5):879-887. PubMed ID: 35098308
    [Abstract] [Full Text] [Related]

  • 20. Seminal factor VII and factor VIIa: supporting evidence for the presence of an active tissue factor-dependent coagulation pathway in human semen.
    Lwaleed BA, Goyal A, Delves G, Gossai S, Greenfield RS, Cooper AJ.
    Int J Androl; 2007 Dec 17; 30(6):543-9. PubMed ID: 17459125
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.